Markus Reindl Selected Research

Disease Progression

1/2023	Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
1/2023	Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum.
8/2021	Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.
1/2021	Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
8/2017	Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
12/2016	Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
6/2015	Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
1/2013	Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
10/2005	Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Reindl Research Topics

Disease

63	Multiple Sclerosis 01/2023 - 10/2002
48	Neuromyelitis Optica (Devic's Disease) 03/2024 - 11/2009
37	Demyelinating Diseases (Demyelinating Disease) 03/2024 - 11/2006
30	Optic Neuritis (Retrobulbar Neuritis) 01/2023 - 09/2011
20	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 07/2008
15	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2023 - 03/2011
14	Myelitis 01/2023 - 05/2010
11	Inflammation (Inflammations) 01/2022 - 08/2004
11	Multiple System Atrophy 01/2020 - 08/2003
10	Transverse Myelitis (Necrotizing Myelitis) 11/2022 - 09/2011
9	Disease Progression 01/2023 - 10/2005
8	Neuroinflammatory Diseases 01/2022 - 11/2007
7	Infections 01/2024 - 12/2004
7	COVID-19 01/2024 - 01/2021
7	Autoimmune Diseases of the Nervous System 11/2021 - 04/2016
7	Nervous System Diseases (Neurological Disorders) 12/2020 - 12/2003
7	Encephalomyelitis (Myeloencephalitis) 09/2020 - 04/2015
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 08/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2016
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 11/2009
5	Leukocytosis (Pleocytosis) 01/2023 - 06/2013
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 08/2003
5	Central Nervous System Diseases (CNS Diseases) 01/2020 - 10/2013
4	Measles 01/2023 - 04/2015
4	Rubella (German Measles) 01/2023 - 04/2015
4	Relapsing-Remitting Multiple Sclerosis 10/2022 - 02/2009
4	Parkinsonian Disorders (Parkinsonism) 01/2020 - 03/2005
4	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2009 - 07/2004
4	Malaria 12/2009 - 07/2004
3	Stroke (Strokes) 04/2023 - 10/2011
3	Ganglion Cysts (Ganglion) 05/2021 - 11/2016
3	Herpes Zoster 09/2020 - 04/2015
3	Synucleinopathies 01/2020 - 08/2011
3	Friedreich Ataxia (Friedreich's Ataxia) 08/2012 - 08/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011 - 05/2010
3	Guillain-Barre Syndrome 10/2011 - 06/2008
3	Atherosclerosis 07/2008 - 07/2002
2	Convalescence 08/2023 - 01/2023
2	Gliosis 01/2020 - 03/2013
2	Seizures (Absence Seizure) 01/2020 - 10/2015
2	Glioma (Gliomas) 10/2016 - 01/2008
2	Ataxia (Dyssynergia) 12/2011 - 08/2011
2	Communicable Diseases (Infectious Diseases) 10/2011 - 12/2009
2	Cerebral Malaria 12/2009 - 02/2009
2	Cerebellar Ataxia (Dysmetria) 09/2005 - 03/2005
2	Striatonigral Degeneration 03/2005 - 08/2003
1	Coronavirus Infections 01/2024
1	Virus Diseases (Viral Diseases) 01/2024

Drug/Important Bio-Agent (IBA)

69	AntibodiesIBA 01/2024 - 07/2003
60	Myelin-Oligodendrocyte GlycoproteinIBA 03/2024 - 10/2002
40	Immunoglobulin G (IgG)IBA 01/2024 - 06/2008
31	AutoantibodiesIBA 11/2022 - 12/2003
20	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2006
11	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2003
9	Oligoclonal BandsIBA 01/2023 - 06/2013
9	CytokinesIBA 01/2023 - 08/2003
8	Complement System Proteins (Complement)IBA 01/2023 - 07/2011
7	Immunoglobulin M (IgM)IBA 01/2024 - 12/2003
7	AntigensIBA 09/2020 - 06/2003
7	Aquaporin 4IBA 01/2020 - 12/2013
6	Immunoglobulins (Immunoglobulin)IBA 08/2023 - 11/2009
6	ChemokinesIBA 01/2023 - 07/2008
6	Aquaporins (Water Channels)IBA 01/2022 - 12/2011
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2022 - 01/2015
5	ImmunosorbentsIBA 01/2019 - 07/2004
5	EnzymesIBA 01/2019 - 07/2004
4	AutoantigensIBA 11/2021 - 01/2007
4	Retinaldehyde (Retinal)IBA 05/2021 - 01/2016
4	Peptides (Polypeptides)IBA 01/2021 - 10/2015
4	alpha-SynucleinIBA 11/2007 - 08/2003
3	Immunoglobulin A (IgA)IBA 01/2024 - 09/2020
3	Rituximab (Mabthera)FDA Link 08/2021 - 05/2013
3	AlbuminsIBA 09/2020 - 10/2011
3	Immunoglobulin IsotypesIBA 09/2020 - 01/2010
3	SynucleinsIBA 01/2020 - 01/2013
3	anti-aquaporin 4 autoantibodyIBA 01/2020 - 09/2011
3	EpitopesIBA 10/2013 - 06/2003
3	Mitochondrial Proteins (Mitochondrial Protein)IBA 08/2012 - 08/2011
3	Erythropoietin FDA Link 08/2012 - 08/2011
3	FrataxinIBA 08/2012 - 08/2011
2	COVID-19 VaccinesIBA 08/2023 - 01/2023
2	2019-nCoV Vaccine mRNA-1273IBA 01/2023 - 01/2022
2	BNT162 VaccineIBA 01/2023 - 01/2022
2	Protein Isoforms (Isoforms)IBA 01/2021 - 05/2010
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2020 - 09/2020
2	SteroidsIBA 11/2016 - 08/2015
2	Glatiramer Acetate (Copaxone)FDA Link 10/2015 - 02/2009
2	Nerve Growth Factor (NGF)IBA 05/2013 - 08/2004
2	Levodopa (L Dopa)FDA LinkGeneric 05/2009 - 09/2005
2	Matrix Metalloproteinases (MMPs)IBA 07/2008 - 06/2008
2	Therapeutic UsesIBA 08/2007 - 11/2006
2	3-nitropropionic acidIBA 03/2005 - 08/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004 - 08/2003
2	Myelin Basic ProteinIBA 07/2003 - 10/2002
1	Nucleocapsid ProteinsIBA 01/2024
1	Serum AlbuminIBA 01/2023

Therapy/Procedure

10	Therapeutics 01/2021 - 07/2004
3	Immunotherapy 01/2020 - 03/2014
1	Musculoskeletal Manipulations (Manipulative Therapy) 04/2023
1	Telerehabilitation 03/2023